| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |